Annual Total Liabilities
$10.48 M
-$156.23 M-93.71%
December 31, 2023
Summary
- As of February 12, 2025, MLYS annual total liabilities is $10.48 million, with the most recent change of -$156.23 million (-93.71%) on December 31, 2023.
- During the last 3 years, MLYS annual total liabilities has risen by +$5.40 million (+106.22%).
- MLYS annual total liabilities is now -93.71% below its all-time high of $166.71 million, reached on December 31, 2022.
Performance
MLYS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$31.32 M
+$2.92 M+10.30%
September 30, 2024
Summary
- As of February 12, 2025, MLYS quarterly total liabilities is $31.32 million, with the most recent change of +$2.92 million (+10.30%) on September 30, 2024.
- Over the past year, MLYS quarterly total liabilities has increased by +$20.84 million (+198.81%).
- MLYS quarterly total liabilities is now -81.21% below its all-time high of $166.71 million, reached on December 31, 2022.
Performance
MLYS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MLYS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -93.7% | +198.8% |
| 3 y3 years | +106.2% | +404.6% |
| 5 y5 years | +106.2% | +404.6% |
MLYS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -93.7% | at low | -81.2% | +404.6% |
| 5 y | 5-year | -93.7% | +106.2% | -81.2% | +404.6% |
| alltime | all time | -93.7% | +106.2% | -81.2% | +404.6% |
Mineralys Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $31.32 M(+10.3%) |
| Jun 2024 | - | $28.40 M(+47.9%) |
| Mar 2024 | - | $19.20 M(+83.2%) |
| Dec 2023 | $10.48 M | $10.48 M(-22.6%) |
| Sep 2023 | - | $13.54 M(+118.2%) |
| Jun 2023 | - | $6.21 M(-41.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $10.56 M(-93.7%) |
| Dec 2022 | $166.71 M(+389.6%) | $166.71 M(+0.5%) |
| Sep 2022 | - | $165.86 M(+387.1%) |
| Dec 2021 | $34.05 M(+569.9%) | - |
| Dec 2021 | - | $34.05 M |
| Dec 2020 | $5.08 M | - |
FAQ
- What is Mineralys Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual total liabilities year-on-year change?
- What is Mineralys Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly total liabilities year-on-year change?
What is Mineralys Therapeutics annual total liabilities?
The current annual total liabilities of MLYS is $10.48 M
What is the all time high annual total liabilities for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual total liabilities is $166.71 M
What is Mineralys Therapeutics annual total liabilities year-on-year change?
Over the past year, MLYS annual total liabilities has changed by -$156.23 M (-93.71%)
What is Mineralys Therapeutics quarterly total liabilities?
The current quarterly total liabilities of MLYS is $31.32 M
What is the all time high quarterly total liabilities for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly total liabilities is $166.71 M
What is Mineralys Therapeutics quarterly total liabilities year-on-year change?
Over the past year, MLYS quarterly total liabilities has changed by +$20.84 M (+198.81%)